CAR T-cells

Videos

HCRU, Costs With CAR-T Therapy Compared to Transplantation for DLBCL

12/17/2020

Karl Kilgore, PhD, discusses study results that showed greater HCRU and costs with CAR-T therapy than transplantation for patients with relapsed/refractory DLBCL.

Karl Kilgore, PhD, discusses...

12/17/2020

Journal of Clinical Pathways

Videos

HCRU and Costs Associated With CAR-T Therapy Toxicity Management in MM

12/08/2020

Journal of Clinical Pathways

News

Economic Model Estimates Total Costs of Tisagenlecleucel Treatment for ALL

09/11/2020

Journal of Clinical Pathways

Research in Review

CAR T-Cells May Have Therapeutic Value in Solid Cancers

06/07/2017

JCP Editors

Chimeric antigen receptor (CAR) T-cells may elicit responses in solid cancers by inducing cancer cell death and the release of tumor antigens that could stimulate T-cell activity, according to research presented at...

...

06/07/2017

Journal of Clinical Pathways